LifeStance Health Group, Inc. (LFST): Cash & Equivalents
$248.64M
As of 2025-12-31
$225.94M
As of 2026-06-30
+31.8%
3-year compound annual growth
+67.6%
5-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $248.64M | +60.9% | 2026-02-25, Balance as of period end |
| 2024-12-31 | $154.57M | +96.1% | 2026-02-25, Balance as of period end |
| 2023-12-31 | $78.82M | -27.4% | 2025-02-27, Balance as of period end |
| 2022-12-31 | $108.62M | -26.6% | 2024-02-28, Balance as of period end |
| 2021-12-31 | $148.03M | +686.2% | 2023-03-09, Balance as of period end |
| 2020-12-31 | $18.83M | n/a | 2022-03-17, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| LifeStance Health Group, Inc. (LFST) | 2025-12-31 | $248.64M | +60.9% |
| P3 Health Partners Inc. (PIII) | 2025-12-31 | $25.01M | -35.6% |
| InnovAge Holding Corp. (INNV) | 2026-06-30 | $97.89M | +52.6% |
| Privia Health Group, Inc. (PRVA) | 2025-12-31 | $479.69M | -2.3% |
| U S Physical Therapy Inc (USPH) | 2025-12-31 | $35.57M | -14.0% |
| GeneDx Holdings Corp. (WGS) | 2025-12-31 | $105.00M | +23.2% |
| DocGo Inc. (DCGO) | 2025-12-31 | $51.02M | -42.8% |
| Omada Health, Inc. (OMDA) | 2025-12-31 | $222.04M | +190.7% |
| Strata Critical Medical, Inc. (SRTA) | 2025-12-31 | $30.97M | +68.5% |
Compare LFST, PIII, INNV, PRVA side by side · Screen every company in Services-Health Services ↗